Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice. 2002

Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
Department of Immunology, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan.

We investigated the generation of CD8 cytotoxic T-lymphocytes (CTL) that recognized a dominant pRL1a peptide bound to H-2L(d) molecule on RL male 1 leukemia in spleen cells from RL male 1-bearing syngeneic BALB/c, semiallogeneic CB6F1 and allogeneic B6 mice by repetitive in vitro stimulation with RL male 1 tumor. CD8 T cells in cultures were also analyzed by H-2L(d)/pRL1a tetramer staining. We showed that pRL1a-specific CTL were more efficiently generated in spleen cells from RL male 1-bearing high responder CB6F1 mice than in low responder BALB/c mice, and this correlated well with the occurrence of H-2L(d)/pRL1a tetramer binding CD8 T cells. Furthermore, we showed that in spleen cells from RL male 1-bearing allogeneic B6 mice, H-2L(d)/pRL1a complex specific CD8 T cells were present at a significant frequency. H-2L(d)/pRL1a recognizing B6 CTL but not BALB/c or CB6F1 CTL gradually lost CD8 expression on their surface by multiplication of in vitro stimulation.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009381 Neoplasms, Radiation-Induced Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation. Radiation-Induced Cancer,Cancer, Radiation-Induced,Radiation-Induced Neoplasms,Cancer, Radiation Induced,Cancers, Radiation-Induced,Neoplasm, Radiation-Induced,Neoplasms, Radiation Induced,Radiation Induced Cancer,Radiation Induced Neoplasms,Radiation-Induced Cancers,Radiation-Induced Neoplasm
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
January 1983, Archivum immunologiae et therapiae experimentalis,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
June 2001, Journal of immunology (Baltimore, Md. : 1950),
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
January 2022, Frontiers in immunology,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
March 1993, Parasite immunology,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
September 2004, European journal of immunology,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
January 1997, Archivum immunologiae et therapiae experimentalis,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
January 2021, Scientific reports,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
December 1991, Scandinavian journal of immunology,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
June 1986, Journal of the National Cancer Institute,
Hidenori Hata, and Akiko Uenaka, and Itsuro Takada, and Akira Kenjo, and Minoru Takahashi, and Toshiro Ono, and Teizo Fujita, and Eiichi Nakayama
August 1966, Journal of the National Cancer Institute,
Copied contents to your clipboard!